Akari Therapeutics Plc
AKTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001541157
No open-market purchases or sales by Akari Therapeutics Plc insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $1.54M in total; no superinvestor holds it.
Members of Congress who traded AKTX
No member of Congress has reported a trade in Akari Therapeutics Plc since 2020.
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.